Menarini India Private Limited (‘Menarini India’), part of the Menarini Group, the world’s largest Italian biopharmaceutical company...
Pharmaceuticals Spotlight
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people...
Regulators are increasingly approving AI-powered endpoints using digital health technologies (DHTs) in drug development. To quantify this...
Chronic diseases are long term ailments that progress over time. They are non-communicable in nature and can...
WuXi Vaccines, a leading contract development and manufacturing organization (CDMO) focused on vaccine discovery, development, and manufacturing,...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO...
RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
2 min read
RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that on...
Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
2 min read
Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of...
‘LEQEMBI® Intravenous Infusion’ approved for the treatment of Alzheimer’s disease in Japan
3 min read
BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that “LEQEMBI® Intravenous Infusion” (200 mg,...
Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology
1 min read
Pierre Fabre Laboratories and Vernalis (R&D) Ltd (“Vernalis”), a fully owned subsidiary of HitGen Inc., are pleased...
